MarketFriction

Indrayani Biotech Ltd

BSE 526445 · Other Agricultural Products
₹9.63 -4.94%
BSE close2026-10-01
Market cap₹83.8 Cr.
P/E38.8

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales42.3140.4439.0944.3831.5330.8117.3250.5729.1035.9535.0137.76
Expenses39.7733.1535.6434.2125.5525.7014.4056.3126.9233.5032.2235.54
Operating Profit2.547.293.4510.175.985.112.92-5.742.182.452.792.22
OPM %6.00%18.03%8.83%22.92%18.97%16.59%16.86%-11.35%7.49%6.82%7.97%5.88%
Other Income0.010.090.081.030.040.300.002.781.061.800.830.88
Interest2.030.931.415.510.831.421.037.072.171.892.473.08
Depreciation0.900.911.030.964.252.791.46-1.720.861.301.011.13
Profit before tax-0.385.541.094.730.941.200.43-8.310.211.060.14-1.11
Tax %15.79%0.00%0.00%0.00%9.57%-1.67%18.60%2.53%23.81%14.15%21.43%-187.39%
Net Profit-0.455.541.084.730.851.220.35-8.530.160.910.120.98
EPS in Rs-0.080.940.130.500.110.160.03-1.090.020.050.020.13
Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales03958502161163165130138
Expenses03957472654145142124128
Operating Profit-0113-571724610
OPM %-105%1.9%0.9%6%-24%11%11%14%4.9%7%
Other Income0000-404135
Interest0001226101210
Depreciation0001013434
Profit before tax-0001-1141211-60
Tax %0%150%300%0%0%0%3%5%6%-620%
Net Profit-0-0-01-1141210-62
EPS in Rs-0.08-0.101.31-1.910.761.490.81-0.780.28
Dividend Payout %0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%46%-5%6%
Compounded Profit Growth%18%-38%135%
Stock Price CAGR4%-18%-43%-23%
Return on Equity%6%1%3%
Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital6444343434464646
Reserves-6-0-027-15-1012222727
Borrowings00014161979113137128
Other Liabilities16975831545852
Total Liabilities11012514051156234268253
Fixed Assets16617151757625860
CWIP-00014141314202627
Investments0000000000
Other Assets04721112285151184166
Total Assets11012514051156234268253
Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity1260416-30-732
Cash from Investing Activity-3-0-4-1-1-47-1625-13
Cash from Financing Activity2-1-1-0-33344-18-15
Net Cash Flow011-112-2-04
Free Cash Flow-222-03-25-47-823
CFO/OP122%331%215%-5%61%94%-128%-124%328%
Mar 2010Mar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days026265284846787165155
Inventory Days36557251444159182147
Days Payable3657077528114110455
Cash Conversion Cycle0262638324630106243247
Working Capital Days-1,883-22-1930-59-126127211163
ROCE %28%12%-13%16%23%14%3%4%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters44.84%33.63%33.57%33.48%33.40%33.28%33.28%33.28%33.26%33.26%33.26%32.92%
DIIs13.11%7.58%6.75%4.07%5.59%5.25%3.66%3.11%3.13%3.13%3.13%3.13%
Public42.05%58.78%59.68%62.46%61.01%61.49%63.07%63.62%63.61%63.61%63.62%63.94%
No. of Shareholders22,59023,03423,95824,13224,41925,25425,12625,70425,68625,56525,50925,811

Fundamentals

Market Cap₹ 83.8 Cr.
Current Price₹ 10.7
Stock P/E38.8
Book Value₹ 9.33
ROCE4.24 %
ROE2.97 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)6%
Compounded Profit Growth (TTM)135%
Consolidated figures.
Valuation
Market capRs 75 Cr
Enterprise valueRs 199 Cr
P/E (TTM)45.28x
Price to book1.03x
Price to sales0.55x
EV / EBITDA14.02x
EV / EBIT20.10x
EV / sales1.45x
Price to cash flow2.37x
Earnings yield2.21%
P/E, 3-year average38.58x
P/B, 3-year average2.32x
P/E, 5-year average29.54x
P/B, 5-year average3.50x
Profitability
Operating margin (excl. other income)6.99%
Operating margin (incl. other income)10.30%
EBITDA margin10.31%
Pre-tax margin0.22%
Net profit margin1.20%
Net margin, latest quarter2.60%
ROE2.97%
ROCE4.82%
ROA0.83%
ROE, 3-year average1.83%
ROCE, 3-year average7.26%
ROA, 3-year average0.55%
ROE, 5-year average10.14%
ROCE, 5-year average11.86%
ROA, 5-year average3.96%
ROIC (approx.)36.23%
Tax rate-620.00%
Other income / net worth6.27%
Growth
Sales growth (latest year)6.01%
Sales CAGR, 3 years-5.35%
Sales CAGR, 5 years45.98%
Profit CAGR, 3 years-37.25%
Sales growth QoQ7.85%
Profit growth QoQ716.67%
Sales growth YoY (latest quarter)-25.33%
Per share
EPS (TTM)Rs 0.21
EPS (latest quarter)Rs 0.13
EPS, 3-year averageRs 0.03
EPS, 5-year averageRs 0.98
Book value per shareRs 9.34
Sales per shareRs 17.66
Cash flow per shareRs 4.05
Free cash flow per shareRs 2.95
Efficiency
Asset turnover0.54x
Fixed asset turnover2.29x
Inventory turnover2.49x
Inventory days147 days
Debtor days155 days
Debtors turnover2.35x
Creditor days55 days
Cash conversion cycle247 days
Working capital days163 days
Leverage
Total debtRs 128 Cr
Cash and bankRs 4 Cr
Net debtRs 124 Cr
Debt to equity1.76x
Net debt / EBITDA8.73x
Interest coverage1.03x
Owners' fund to total sources28.76%
Debt to assets50.63%
Cash flow
Cash from Operating Activity (latest year)Rs 32 Cr
Cash from Investing Activity (latest year)Rs -13 Cr
Cash from Financing Activity (latest year)Rs -15 Cr
Net Cash Flow (latest year)Rs 4 Cr
Free cash flow (latest year)Rs 23 Cr
FCFE (approx.: FCF + change in debt)Rs 14 Cr
Cash from ops / profit, 5 years0.68x
Sales to cash flow4.35x
Statement figures
Net sales (TTM)Rs 138 Cr
Net sales (latest year)Rs 138 Cr
Sales (latest quarter)Rs 38 Cr
Operating profit excl. other income (latest year)Rs 10 Cr
Operating profit (latest quarter)Rs 2 Cr
Other income (TTM)Rs 5 Cr
EBITDA (TTM)Rs 14 Cr
PBDT (TTM)Rs 5 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs -2 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 4 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 10 Cr
Cost of goods sold (latest year)Rs 94 Cr
Total expenditure (latest year)Rs 128 Cr
Total income (latest year)Rs 142 Cr
Share capitalRs 46 Cr
ReservesRs 27 Cr
Shareholders' fundsRs 73 Cr
Total assetsRs 253 Cr
Net blockRs 60 Cr
Capital work in progressRs 27 Cr
InvestmentsRs 0 Cr
ReceivablesRs 59 Cr
InventoryRs 38 Cr
Other liabilitiesRs 52 Cr
Shares outstanding (crore)7.81
Ownership
Promoter holding32.92% (-0.36 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 26.4 is at the 15th percentile of its own 4.4-year range (median 38.3, low 11.5, high 105.4).
P/B 0.60 is at the 4th percentile (median 6.71).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period526445Nifty 50Difference
1 week-2.4%-2.8% +0.3 pts
1 month+20.7%-6.8% +27.5 pts
3 months+7.0%-7.6% +14.6 pts
3 years-83.6%+14.2% -97.7 pts
5 years-67.7%+27.9% -95.6 pts

Red flags

F-score 8 of 8
explainWeak cash conversion Cash from operations was -226% of net profit over the last 3 years
explainShare dilution Share count up 0% in a year, 33% in three
explainLow interest cover Interest cover 1.0x in 2026
lookProfit leans on other income Other income was 1523% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Mar 2026
Sales ₹38 Cr -25.3% vs Mar 2025. Net profit ₹1 Cr +111.5%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
L T Foods Ltd13,98721.817.6 %
KRBL Ltd8,84011.715.2 %
Gujarat Ambuja Exports Ltd7,41917.712.5 %
TruAlt Bioenergy Ltd3,94025.210.4 %
Kaveri Seed Company Ltd3,80115.215.8 %
Sanstar Ltd2,12248.25.69 %
Amir Chand Jagdish Kumar (Exports) Ltd2,09116.915.7 %
GRM Overseas Ltd1,63221.314.0 %
AVT Natural Products Ltd1,40316.714.2 %
Chamanlal Setia Exports Ltd1,40111.218.2 %
Gulshan Polyols Ltd1,0276.9618.6 %
Regaal Resources Ltd90914.012.0 %
Bombay Super Hybrid Seeds Ltd89331.116.0 %
True Green Bio Energy Ltd62211.613.8 %
Mangalam Global Enterprise Ltd53314.417.0 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Indrayani Biotech Ltd?

Indrayani Biotech Ltd (526445) has a market capitalisation of Rs 83.8 Cr. at the 2026-10-01 close.

What is the P/E ratio of Indrayani Biotech Ltd?

Indrayani Biotech Ltd trades at a P/E of 38.8 on trailing twelve-month profit, at the 2026-10-01 close.

What were Indrayani Biotech Ltd's latest quarterly results?

In the Mar 2026 quarter, Indrayani Biotech Ltd sales was Rs 38 Cr (-25.3% vs Mar 2025) and net profit was Rs 1 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03